Top

Osteoporosis International

Published in:

01-03-2015 | Original Article

Effect of estrogen deficiency on the fixation of titanium implants in chronic kidney disease mice

Authors: S. Zhang, Y. Guo, H. Zou, N. Sun, D. Zhao, W. Liu, Y. Dong, G. Cheng, Q. Yuan

Published in: Osteoporosis International | Issue 3/2015

Abstract

Summary

We established a chronic kidney disease (CKD) mouse model with estrogen deficiency and inserted titanium implants into the femur of such mice to investigate the fixation of the implants. Both the histomorphometry and implant resistance indicated that estrogen deficiency impaired the fixation of titanium implants inserted into such mice.

Introduction

CKD has been regarded as a worldwide public health problem. Estrogen is a critical factor for both renal protection and bone remodeling. A previous study demonstrated that CKD impairs the early healing of titanium implants. However, the combined effect of estrogen deficiency and CKD on the fixation of titanium implants is largely unknown.

Methods

Forty 9-week-old female C57BL mice were randomly divided into sham, ovariectomy (OVX), CKD, and CKD + OVX groups. Uremia and estrogen deficiency were induced by 5/6 nephrectomy and OVX, respectively. Experimental titanium implants were inserted into the distal end of the femur. Bone-implant contact (BIC) ratio and bone volume (BV/TV) around the implants were histomorphometrically analyzed. The fixation strength of the implant was measured by a biomechanical push-in resistance test.

Results

Serum measurement confirmed a significant increase in serum blood urea nitrogen (BUN) in the CKD group, which was further increased by OVX. Estrogen deficiency led to significant decreases in the BIC ratio, BV/TV, and the push-in resistance in CKD animals. There was a significant interaction between the effects of OVX and CKD, with OVX exacerbating the effects of CKD on BIC ratio and push-in resistance.

Conclusions

The results indicated that estrogen deficiency exerts a synergistic effect with CKD and further impairs the fixation of titanium implants in CKD mice.

Zhang L, Wang F, Wang L et al (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379:815–822CrossRefPubMed

Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS (2007) Prevalence of chronic kidney disease in the United States. JAMA J Am Med Assoc 298:2038–2047CrossRef

Kimura G (2007) Predicted prevalence in Japan of chronic kidney disease (CKD). Clin Exp Nephrol 11:188–189CrossRefPubMed

Gal-Moscovici A, Sprague SM (2007) Bone health in chronic kidney disease-mineral and bone disease. Adv Chronic Kidney Dis 14:27–36CrossRefPubMed

Moe S, Drueke T, Cunningham J et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945–1953CrossRefPubMed

Lee MM, Chu EY, El-Abbadi MM, Foster BL, Tompkins KA, Giachelli CM, Somerman MJ (2010) Characterization of mandibular bone in a mouse model of chronic kidney disease. J Periodontol 81:300–309CrossRefPubMedCentralPubMed

Zou H, Zhao X, Sun N et al (2013) Effect of chronic kidney disease on the healing of titanium implants. Bone 56:410–415CrossRefPubMed

Neugarten J (2002) Gender and the progression of renal disease. J Am Soc Nephrol JASN 13:2807–2809CrossRef

Diamond JR, Karnovsky MJ (1988) Focal and segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int 33:917–924CrossRefPubMed

10.

Kummer S, von Gersdorff G, Kemper MJ, Oh J (2012) The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease. Pediatr Nephrol 27:1213–1219CrossRefPubMed

11.

Gross ML, Adamczak M, Rabe T, Harbi NA, Krtil J, Koch A, Hamar P, Amann K, Ritz E (2004) Beneficial effects of estrogens on indices of renal damage in uninephrectomized SHRsp rats. J Am Soc Nephrol JASN 15:348–358CrossRef

12.

Hutchens MP, Fujiyoshi T, Komers R, Herson PS, Anderson S (2012) Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo. Am J Physiol Renal Physiol 303:F377–F385CrossRefPubMedCentralPubMed

13.

Berg UB (2006) Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors. Nephrol Dial Transplant Off Public Euro Dial Transplant Assoc Euro Renal Assoc 21:2577–2582

14.

Manolagas SC, Bellido T, Jilka RL (1995) Sex steroids, cytokines and the bone marrow: new concepts on the pathogenesis of osteoporosis. Ciba Found Sympos 191:187–196, discussion 197-202

15.

Eastell R (2005) Role of oestrogen in the regulation of bone turnover at the menarche. J Endocrinol 185:223–234CrossRefPubMed

16.

Riggs BL (2000) The mechanisms of estrogen regulation of bone resorption. J Clin Invest 106:1203–1204CrossRefPubMedCentralPubMed

17.

Richelson LS, Wahner HW, Melton LJ 3rd, Riggs BL (1984) Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med 311:1273–1275CrossRefPubMed

18.

Riggs BL (2002) Endocrine causes of age-related bone loss and osteoporosis. Novartis Found Symp 242:247–259, discussion 260-244CrossRefPubMed

19.

Tateishi H, Okamoto Y, Kinoshita K, Hibi H, Ueda M (2013) Effects of implant surface on bone healing around titanium screw implants in ovariectomized rats. Int J Oral Maxillofacial Imp 28:e252–e259CrossRef

20.

de Deco CP, da Silva Marchini AM, Barbara MA, de Vasconcellos LM, da Rocha RF, Marchini L (2011) Negative effects of alcohol intake and estrogen deficiency combination on osseointegration in a rat model. J Oral Implantol 37:633–639CrossRefPubMed

21.

Giro G, Coelho PG, Pereira RM, Jorgetti V, Marcantonio E Jr, Orrico SR (2011) The effect of oestrogen and alendronate therapies on postmenopausal bone loss around osseointegrated titanium implants. Clin Oral Impl Res 22:259–264CrossRef

22.

Giro G, Goncalves D, Sakakura CE, Pereira RM, Marcantonio Junior E, Orrico SR (2008) Influence of estrogen deficiency and its treatment with alendronate and estrogen on bone density around osseointegrated implants: radiographic study in female rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontics 105:162–167CrossRef

23.

Duarte PM, Goncalves PF, Casati MZ, Sallum EA, Nociti FH Jr (2005) Age-related and surgically induced estrogen deficiencies may differently affect bone around titanium implants in rats. J Periodontol 76:1496–1501CrossRefPubMed

24.

Weisinger JR, Gonzalez L, Alvarez H, Hernandez E, Carlini RG, Capriles F, Cervino M, Martinis R, Paz-Martinez V, Bellorin-Font E (2000) Role of persistent amenorrhea in bone mineral metabolism of young hemodialyzed women. Kidney Int 58:331–335CrossRefPubMed

25.

Barreto FC, Barreto DV, Moyses RM, Neves CL, Jorgetti V, Draibe SA, Canziani ME, Carvalho AB (2006) Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem. Kidney Int 69:1852–1857CrossRefPubMed

26.

Naves Diaz M, Rodriguez Rodriguez A, Fernandez Martin JL, Serrano Arias M, Menendez Rodriguez P, Cannata Andia JB (2007) Effects of estradiol, calcitriol and both treatments combined on bone histomorphometry in rats with chronic kidney disease and ovariectomy. Bone 41:614–619CrossRefPubMed

27.

Gagnon RF, Gallimore B (1988) Characterization of a mouse model of chronic uremia. Urol Res 16:119–126CrossRefPubMed

28.

Lasota A, Danowska-Klonowska D (2004) Experimental osteoporosis—different methods of ovariectomy in female white rats. Rocz Akad Med Bialymst 49(Suppl 1):129–131PubMed

29.

Golde WT, Gollobin P, Rodriguez LL (2005) A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab Animal 34:39–43CrossRefPubMed

30.

Gava AL, Freitas FP, Meyrelles SS, Silva IV, Graceli JB (2011) Gender-dependent effects of aging on the kidney. Brazilian Journal of Medical and Biological Research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica [et al.] 44:905–913

31.

Gluhovschi G, Gluhovschi A, Anastasiu D, Petrica L, Gluhovschi C, Velciov S (2012) Chronic kidney disease and the involvement of estrogen hormones in its pathogenesis and progression. Roman J Int Med Rev Roumaine de Med Int 50:135–144

32.

Neugarten J, Acharya A, Silbiger SR (2000) Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol JASN 1:319–329

33.

Fung MM, Poddar S, Bettencourt R, Jassal SK, Barrett-Connor E (2011) A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo study. Menopause 18:629–637CrossRefPubMedCentralPubMed

34.

Fink HA, Ishani A, Taylor BC, Greer NL, MacDonald R, Rossini D, Sadiq S, Lankireddy S, Kane RL, Wilt TJ (2012) Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med 156:570–581CrossRefPubMed

35.

Matuszkiewicz-Rowinska J (2010) KDIGO clinical practice guidelines for the diagnosis, evaluation, prevention, and treatment of mineral and bone disorders in chronic kidney disease. Pol Arch Med Wewn 120:300–306PubMed

36.

Manolagas SC (2010) From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 31:266–300CrossRefPubMedCentralPubMed

37.

Riggs BL, Khosla S, Melton LJ 3rd (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279–302CrossRefPubMed

38.

Manolagas SC (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115–137PubMed

39.

Cai XX, Luo E, Yuan Q (2010) Interaction between Schwann cells and osteoblasts in vitro. Int J Oral Sci 2:74–81CrossRefPubMedCentralPubMed

40.

Hernandez E, Valera R, Alonzo E, Bajares-Lilue M, Carlini R, Capriles F, Martinis R, Bellorin-Font E, Weisinger JR (2003) Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis. Kidney Int 63:2269–2274CrossRefPubMed

41.

Heilberg IP, Hernandez E, Alonzo E, Valera R, Ferreira LG, Gomes SA, Bellorin-Font E, Weisinger JR (2005) Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on chronic hemodialysis. Ren Fail 27:155–161PubMed

42.

Eriguchi R, Umakoshi J, Miura S, Sato Y (2009) Raloxifene ameliorates progressive bone loss in postmenopausal dialysis patients with controlled parathyroid hormone levels. Clin Nephrol 72:423–429CrossRefPubMed

Title: Effect of estrogen deficiency on the fixation of titanium implants in chronic kidney disease mice
Authors: S. Zhang
Y. Guo
H. Zou
N. Sun
D. Zhao
W. Liu
Y. Dong
G. Cheng
Q. Yuan
Publication date: 01-03-2015
Publisher: Springer London
Published in: Osteoporosis International / Issue 3/2015
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-014-2952-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effect of estrogen deficiency on the fixation of titanium implants in chronic kidney disease mice

Abstract

Summary

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2015

Incorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan

Anthropometric models of bone mineral content and areal bone mineral density based on the bone mineral density in childhood study

Bone quality in osteopenic postmenopausal women is not improved after 12 months of whole-body vibration training

Adult bone strength of children from single-parent families: the Midlife in the United States Study

Ten-year incidences of self-reported non-vertebral fractures in Japanese patients with rheumatoid arthritis: discrepancy between disease activity control and the incidence of non-vertebral fracture

Predictors of 25(OH)D half-life and plasma 25(OH)D concentration in The Gambia and the UK